148 related articles for article (PubMed ID: 11336071)
1. Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria.
Kulthanan K; Gritiyarangsan P; Sitakalin C; Charuwichitratana S; Korkij W; Aunhachoke K; Janjumratsang P; Jiamton S; Kuntiranont M; Krisadapong J; Gherunpong N; Kullavanijaya P
J Med Assoc Thai; 2001 Feb; 84(2):153-9. PubMed ID: 11336071
[TBL] [Abstract][Full Text] [Related]
2. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
Nelson HS; Reynolds R; Mason J
Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
[TBL] [Abstract][Full Text] [Related]
3. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
Kaplan AP; Spector SL; Meeves S; Liao Y; Varghese ST; Georges G
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):662-9. PubMed ID: 15984599
[TBL] [Abstract][Full Text] [Related]
4. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria.
Thompson AK; Finn AF; Schoenwetter WF
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):24-30. PubMed ID: 10863219
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
Finn AF; Kaplan AP; Fretwell R; Qu R; Long J
J Allergy Clin Immunol; 1999 Nov; 104(5):1071-8. PubMed ID: 10550755
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life.
Lennox RD; Leahy MJ
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):142-6. PubMed ID: 15328673
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
[TBL] [Abstract][Full Text] [Related]
8. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
Augustin M; Ehrle S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
[TBL] [Abstract][Full Text] [Related]
10. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
Kapp A; Pichler WJ
Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
[TBL] [Abstract][Full Text] [Related]
11. A non-comparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis.
Bunnag C; Jareoncharsri P; Tunsuriyawong P; Pumhirun P; Limprasertsiri S; Chochaipanichnon L; Supiyaphun P; Kongpatanakul S
Asian Pac J Allergy Immunol; 2000 Sep; 18(3):127-33. PubMed ID: 11270466
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
Belaich S; Bruttmann G; DeGreef H; Lachapelle JM; Paul E; Pedrali P; Tennstedt D
Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
Saini S; Rosen KE; Hsieh HJ; Wong DA; Conner E; Kaplan A; Spector S; Maurer M
J Allergy Clin Immunol; 2011 Sep; 128(3):567-73.e1. PubMed ID: 21762974
[TBL] [Abstract][Full Text] [Related]
14. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
Simpson K; Jarvis B
Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552
[TBL] [Abstract][Full Text] [Related]
15. The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria.
Spector SL; Shikiar R; Harding G; Meeves S; Leahy MJ
Cutis; 2007 Feb; 79(2):157-62. PubMed ID: 17388220
[TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis.
Hampel FC; Kittner B; van Bavel JH
Ann Allergy Asthma Immunol; 2007 Dec; 99(6):549-54. PubMed ID: 18219837
[TBL] [Abstract][Full Text] [Related]
17. [Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria].
Lambert D; Hantzperg M; Danglas P; Bloom M
Allerg Immunol (Paris); 1993 Jun; 25(6):235-40. PubMed ID: 8357472
[TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria.
Paul E; Reinel D; Ulrich R; Köhler ME
Ann Allergy; 1989 Oct; 63(4):340-2. PubMed ID: 2572189
[TBL] [Abstract][Full Text] [Related]
19. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Sastre J
Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.
Casale TB; Andrade C; Qu R
Allergy Asthma Proc; 1999; 20(3):193-8. PubMed ID: 10389553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]